These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21364347)

  • 1. Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetine.
    Nardi AE; Valença AM; Freire RC; Amrein R; Sardinha A; Levitan MN; Nascimento I; de-Melo-Neto VL; King AL; de O e Silva AC; Veras AB; Dias GP; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    J Clin Psychopharmacol; 2011 Apr; 31(2):259-61. PubMed ID: 21364347
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine.
    Nardi AE; Freire RC; Mochcovitch MD; Amrein R; Levitan MN; King AL; Valença AM; Veras AB; Paes F; Sardinha A; Nascimento I; de-Melo-Neto VL; Dias GP; E Silva AC; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    J Clin Psychopharmacol; 2012 Feb; 32(1):120-6. PubMed ID: 22198456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment.
    Nardi AE; Freire RC; Valença AM; Amrein R; de Cerqueira AC; Lopes FL; Nascimento I; Mezzasalma MA; Veras AB; Sardinha A; de Carvalho MR; da Costa RT; Levitan MN; de-Melo-Neto VL; Soares-Filho GL; Versiani M
    J Clin Psychopharmacol; 2010 Jun; 30(3):290-3. PubMed ID: 20473065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
    Nardi AE; Valença AM; Freire RC; Mochcovitch MD; Amrein R; Sardinha A; Levitan MN; Nascimento I; de-Melo-Neto VL; King AL; de O E Silva AC; Veras AB; Dias GP; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    Braz J Med Biol Res; 2011 Apr; 44(4):366-73. PubMed ID: 21344132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in anxiety sensitivity with pharmacotherapy for panic disorder.
    Simon NM; Otto MW; Smits JA; Nicolaou DC; Reese HE; Pollack MH
    J Psychiatr Res; 2004; 38(5):491-5. PubMed ID: 15380399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium valproate and clonazepam for treatment-resistant panic disorder.
    Ontiveros A; Fontaine R
    J Psychiatry Neurosci; 1992 Jun; 17(2):78-80. PubMed ID: 1637803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder.
    Worthington JJ; Pollack MH; Otto MW; McLean RY; Moroz G; Rosenbaum JF
    Psychopharmacol Bull; 1998; 34(2):199-205. PubMed ID: 9641001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.
    Toni C; Perugi G; Frare F; Mata B; Vitale B; Mengali F; Recchia M; Serra G; Akiskal HS
    Pharmacopsychiatry; 2000 Jul; 33(4):121-31. PubMed ID: 10958260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
    Pollack MH; Otto MW; Tesar GE; Cohen LS; Meltzer-Brody S; Rosenbaum JF
    J Clin Psychopharmacol; 1993 Aug; 13(4):257-63. PubMed ID: 8376613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine in panic disorder: clinical management and long-term follow-up.
    Dannon PN; Lowengrub K; Iancu I; Kotler M
    Expert Rev Neurother; 2004 Mar; 4(2):191-8. PubMed ID: 15853560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of panic disorder: focus on paroxetine.
    Pollack MH; Doyle AC
    Psychopharmacol Bull; 2003; 37 Suppl 1():53-63. PubMed ID: 14566201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of clonazepam on quality of life and work productivity in panic disorder.
    Jacobs RJ; Davidson JR; Gupta S; Meyerhoff AS
    Am J Manag Care; 1997 Aug; 3(8):1187-96. PubMed ID: 10170301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma.
    Labbate LA; Pollack MH; Otto MW; Tesar GM; Rosenbaum JF
    J Clin Psychopharmacol; 1994 Aug; 14(4):274-6. PubMed ID: 7962684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response.
    Beauclair L; Fontaine R; Annable L; Holobow N; Chouinard G
    J Clin Psychopharmacol; 1994 Apr; 14(2):111-8. PubMed ID: 8195451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam.
    Nardi AE; Valença AM; Nascimento I; Lopes FL; Mezzasalma MA; Freire RC; Veras AB; Zin WA; Versiani M
    Psychiatry Res; 2005 Nov; 137(1-2):61-70. PubMed ID: 16226812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 6-Year Posttreatment Follow-up of Panic Disorder Patients: Treatment With Clonazepam Predicts Lower Recurrence Than Treatment With Paroxetine.
    Freire RC; Amrein R; Mochcovitch MD; Dias GP; Machado S; Versiani M; Arias-Carrión O; Carta MG; Nardi AE
    J Clin Psychopharmacol; 2017 Aug; 37(4):429-434. PubMed ID: 28609307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbid cannabis use and panic disorder: short term and long term follow-up study.
    Dannon PN; Lowengrub K; Amiaz R; Grunhaus L; Kotler M
    Hum Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 14994319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.
    Pecknold JC; Luthe L; Iny L; Ramdoyal D
    J Psychiatry Neurosci; 1995 May; 20(3):193-8. PubMed ID: 7786880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.